Adani Ports

693.55down-arrow-1.15

Asian Paints

2988.4down-arrow-30.20

Axis Bank

749.3down-arrow-4.50

B P C L

453.5down-arrow-3.65

Bajaj Auto

3818.75down-arrow-13.25

Bajaj Finance

6248.25down-arrow-110.90

Bajaj Finserv

13994.9down-arrow-192.30

Bharti Airtel

598.7down-arrow24.30

Britannia Inds.

3611.15down-arrow32.85

Cipla

945.4down-arrow5.75

Coal India

145.45down-arrow0.75

Divi's Lab.

4923.55down-arrow-40.70

Dr Reddy's Labs

4782.3down-arrow13.50

Eicher Motors

2732.15down-arrow90.35

Grasim Inds

1537.4down-arrow-17.45

H D F C

2661.7down-arrow-14.35

HCL Technologies

1061.15down-arrow21.20

HDFC Bank

1484.85down-arrow19.55

HDFC Life Insur.

669.5down-arrow-5.80

Hero Motocorp

2818.8down-arrow13.30

Hind. Unilever

2357.7down-arrow-19.40

Hindalco Inds.

443.1down-arrow0.40

I O C L

103.95down-arrow-1.35

ICICI Bank

702.45down-arrow-12.20

IndusInd Bank

997.7down-arrow-22.85

Infosys

1653.55down-arrow4.30

ITC

215.25down-arrow6.65

JSW Steel

763.25down-arrow16.00

Kotak Mah. Bank

1771.75down-arrow21.80

Larsen & Toubro

1627.4down-arrow4.20

M & M

759.35down-arrow-6.90

Maruti Suzuki

7027.55down-arrow-75.35

Nestle India

18208.75down-arrow151.40

NTPC

116.5down-arrow-1.35

O N G C

116.85down-arrow-0.50

Power Grid Corpn

175.2down-arrow-0.05

Reliance Industr

2134.25down-arrow30.50

SBI Life Insuran

1134.75down-arrow-2.10

Shree Cement

28966.65down-arrow-166.50

St Bk of India

441.85down-arrow-15.10

Sun Pharma.Inds.

786.15down-arrow0.40

Tata Consumer

768.35down-arrow9.60

Tata Motors

299.7down-arrow1.55

Tata Steel

1446.6down-arrow30.40

TCS

3283.95down-arrow10.00

Tech Mahindra

1248.2down-arrow31.70

Titan Company

1799.3down-arrow-0.30

UltraTech Cem.

7659down-arrow-91.00

UPL

777.25down-arrow-7.75

Wipro

600.9down-arrow4.10

Corporate News - Detailed News Back
Natco Pharma receives USFDA approval for Carfilzomib Vials ANDA
14-Jun-21   12:56 Hrs IST
Natco Pharma has received approval for its Abbreviated New Drug Application (ANDA) for Carfilzomib Vials ANDA (generic for KYPROLIS®), from the U.S. Food and Drug Administration (USFDA).

The parties have received final approval for 10mg and 60mg strengths of the product and tentative approval for 30mg strength of the product. Based on the ANDA filing date NATCO believes that it is eligible for 180 days of sole generic marketing exclusivity for the 10mg strength and shared 180 days of generic marketing exclusivity for the 60mg strength of the product at the time of launch.

Powered by Capital Market - Live News


NASDAQ 14780.53
19.23 0.13%
DJIA 34792.67
-323.73 -0.92%
S&P 500 4402.66
-20.49 -0.46%
HANG SENG 26204.69
-221.86 -0.84%
NIKKEI 225 27728.12
144.04 0.52%
STRAITS TIMES 3175.10
-7.80 -0.25%
FTSE 100 7120.43
-3.43 -0.05%
KLSE COMPOSITE 1495.78
4.45 0.30%
JAKARTA COMPOSITE 6205.42
46.38 0.75%
BSE SENSEX 54492.84
123.07 0.23%
NIFTY 16294.60
35.80 0.22%